Walgreens Agrees to Pay $269 Million to U.S. in Fraud Accord (2)

Walgreens Boots Alliance Inc. agreed to pay $269.2 million to settle U.S. claims that the drugstore chain defrauded a federally-funded health-care program over insulin drugs and a consumer-discount initiative.

The two settlements, announced Jan. 22, cover allegations over improper billing. In the first one, the company agreed to pay $209.2 million to resolve claims it billed Medicare, Medicaid and other programs for hundreds of thousands of insulin pens it distributed to people who didn’t need them. In the second, Walgreens said it would pay $60 million for overbilling Medicaid by not disclosing lower drug prices it offered in a discount ...